FDA Clearance Tracker · P110033-S099
SKINVIVE by JUVEDERM®
Last checked: Nov 20, 2026Latest source record: Jun 11, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jun 11, 2026
Approved
Time to decision
394 days
Received May 13, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
Device type
- Device type
- Implant, dermal, for aesthetic use (LMH)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
SKINVIVE by JUVÉDERM® is indicated for intradermal injection to improve skin smoothness of the cheeks and intradermal and/or subdermal injection to reduce neck lines for improvement of neck appearance in adults over the age of 21
Source documents
Other decisions for Allergan
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K233732 · Decided Sep 12, 2024 · 296 days after receipt
Device type: Dermal Cooling Pack/Vacuum/Massager (OOK) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.